The list included not only several TFs known to be deregulated in CRC, for example c-MYC (He et al, 1998) and SOX9 (Blache et al, 2004), but also many for which this information was novel for example, CBFB and SMARCC1. This evidence concerns the gene SMARCC1 and colorectal carcinoma.